Dow Up 0.57% Nasdaq Down 0.39%

Gilead Sciences Inc. (GILD)

-NasdaqGS
113.57 Up 2.85(2.57%) 10:46AM EDT - Nasdaq Real Time Price
Prev Close:110.72
Open:110.72
Bid:113.37 x 300
Ask:113.40 x 800
1y Target Est:118.08
Beta:0.98
Next Earnings Date:N/A
Day's Range:110.60 - 114.35
52wk Range:63.50 - 114.35
Volume:4,745,272
Avg Vol (3m):14,365,100
Market Cap:171.93B
P/E (ttm):25.73
EPS (ttm):4.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
GILDUp 2.57%171.93B
GSKDown 0.21%108.14B
PFEUp 0.50%187.92B
RHHBYUp 0.56%250.97B

Key Statistics

Forward P/E (1 yr):11.75
P/S (ttm):8.10
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.05
Quarterly EPS Est (Sep-14) :1.92
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.58

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback